During the past decade, Ilke Kupeli conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ilke Kupeli" are "Interleukin-6" (1 trials), "Pain, Postoperative" (1 trials), "Satisfaction, Personal" (1 trials) and "Short-term (3 Days) High-dose (1000 mg) Systemic Methylprednisolone" (1 trials). Many other conditions were trialed in "Ilke Kupeli" in a lesser frequency.

Most popular intervention types in "Ilke Kupeli" are "Behavioral" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Awareness Level" (1 trials), "cytokine hemadsorption" (1 trials), "pain" (1 trials) and "systemic methylprednisolone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ilke Kupeli" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ilke Kupeli". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ilke Kupeli, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ilke Kupeli, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".